Synchron's Thought-Controlled iPad Breakthrough Revolutionizes Assistive Tech, Empowering ALS Patients

August 4, 2025
Synchron's Thought-Controlled iPad Breakthrough Revolutionizes Assistive Tech, Empowering ALS Patients
  • Synchron has achieved a groundbreaking milestone by demonstrating the first-ever thought-controlled iPad experience using Apple's Brain-Computer Interface (BCI) Human Interface Device protocol, a significant advancement in assistive technology.

  • The Stentrode implant, which is minimally invasive and inserted via blood vessels, detects neural signals associated with motor intentions and wirelessly transmits them to external devices.

  • Mark Jackson, a 65-year-old man with ALS, has successfully utilized Synchron's BCI to engage in activities such as playing computer games, texting, and shopping online, significantly enhancing his independence.

  • Synchron has garnered substantial financial backing, including investments from Gates Frontier and Bezos Expeditions, and initial support from DARPA grants.

  • Since 2019, Synchron has been conducting human trials and is preparing for larger-scale studies following a $75 million funding round in 2022, bringing its total funding to $145 million.

  • The company is pursuing FDA regulatory approval through the Class III medical device pathway, having completed pivotal clinical trials that build trust with healthcare providers and insurers.

  • Synchron is gearing up for a pivotal trial in 2026 to collect data necessary for FDA approval, demonstrating that the benefits of the device outweigh its risks.

  • Jackson expressed that this technology has restored part of his independence, enabling him to communicate and engage with the world through cognitive control.

  • Dr. Tom Oxley, CEO of Synchron, described this development as a significant technical breakthrough in human-computer interaction, where cognitive input could become a standard control method.

  • The system employs Apple's Switch Control accessibility feature, facilitating closed-loop communication that allows for real-time adjustments, enhancing user control through neural signals.

  • Synchron plans to launch its product with clinical trial participants using Apple devices in late 2025, emphasizing user-friendly design and accessibility.

  • The potential applications of this technology extend beyond communication, offering new opportunities in education, rehabilitation, and even remote work in virtual environments.

Summary based on 15 sources


Get a daily email with more Tech stories

More Stories